We are pleased to summarise the results of the most recent 400 verified respondents to the survey below. The survey continues, as does the antidepressant survey . The antipsychotic survey has detected a consolidation of the impact of the new drug, olanzapine. A high proportion of new preference loggings in the US and Canada are for olanzapine. Risperidone continues to hold a significant preference share in Europe and South America.
Arrows indicate the trend of preferences in recent months.
The UK Department of Health is making 240,000 available for research relevant to the evaluation of the 1995 Patients in the Community Act. 11 were officially poor and only 16 were good or exemplary. Half were not using recommended machines and two thirds of doctors administering ECT were very junior trainees. Nevertheless the audit showed an improvement since the previous audit of 1991. MIND, the national mental health charity, called for a wider audit still.